Levels of oxidized low-density lipoproteins are increased in patients with severe sepsis

Journal of Critical Care

Volumn 23, Issue 4, 2008, Pages 537-541

  Behnes, Michael ^a   Brueckmann, Martina ^a   Liebe, Volker ^a   Liebetrau, Claudia ^a   Lang, Siegfried ^a   Putensen, Christian ^b   Borggrefe, Martin ^a   Hoffmann, Ursula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Drotrecogin (activated); Oxidative stress; Oxidized low density lipoprotein; Sepsis

Indexed keywords

DROTRECOGIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; SEPSIS;

ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROTEIN C; RECOMBINANT PROTEINS; SEPSIS;

EID: 56849098695     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2008.09.002     Document Type: Article

References (29)

1. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
2. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003) 1250-1256
3. Dhainaut J.F., Shorr A.F., Macias W.L., et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 33 (2005) 341-348
4. Bone R.C., Grodzin C.J., and Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112 (1997) 235-243
5. Gutteridge J.M., and Mitchell J. Redox imbalance in the critically ill. Br Med Bull 55 (1999) 49-75
6. Alonso de Vega J.M., Diaz J., Serrano E., et al. Plasma redox status relates to severity in critically ill patients. Crit Care Med 28 (2000) 1812-1814
7. Alonso de Vega J.M., Diaz J., Serrano E., et al. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30 (2002) 1782-1786
8. Motoyama T., Okamoto K., Kukita I., et al. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31 (2003) 1048-1052
9. Gaut J.P., and Heinecke J.W. Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc Med 11 (2001) 103-112
10. Memon R.A., Staprans I., Noor M., et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 20 (2000) 1536-1542
11. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 18 (2000) 655-673
12. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
13. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
14. Tsimikas S., Bergmark C., Beyer R.W., et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41 (2003) 360-370
15. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
16. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
17. Kalayoglu M.V., Hoerneman B., LaVerda D., et al. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 180 (1999) 780-790
18. Sedgwick J.B., Hwang Y.S., Gerbyshak H.A., et al. Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am J Respir Cell Mol Biol 29 (2003) 702-709
19. Silva A.R., de Assis E.F., Caiado L.F., et al. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J Immunol 168 (2002) 4112-4120
20. Dimmeler S., Haendeler J., Galle J., et al. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the "response to injury" hypothesis. Circulation 95 (1997) 1760-1763
21. Galle J., Schneider R., Heinloth A., et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney Int 55 (1999) 1450-1461
22. Heermeier K., Leicht W., Palmetshofer A., et al. Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cells. J Am Soc Nephrol 12 (2001) 456-463
23. Hoffmann J.N., Vollmar B., Laschke M.W., et al. Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition. Crit Care 9 Suppl 4 (2005) S33-S37
24. Hoffmann J.N., Vollmar B., Laschke M.W., et al. Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 32 (2004) 1011-1017
25. Bochkov V.N., and Leitinger N. Anti-inflammatory properties of lipid oxidation products. J Mol Med 81 (2003) 613-626
26. Safa O., Hensley K., Smirnov M.D., et al. Lipid oxidation enhances the function of activated protein C. J Biol Chem 276 (2001) 1829-1836
27. Hughes M. Recombinant human activated protein C. Int J Antimicrob Agents 28 (2006) 90-94
28. Cheng T., Liu D., Griffin J.H., et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9 (2003) 338-342
29. Joyce D.E., and Grinnell B.W. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 30 (2002) S288-S293